Heart Failure Clinical Trial
— FAIROfficial title:
Maintenance of Physical Activity After Cardiac Rehabilitation: a Feasibility Trial
Physical activity is a key element in cardiac rehabilitation and prevention of cardiovascular mortality and hospitalizations. After cardiac rehabilitation programs end, physical activity levels and participation in continued cardiac rehabilitation declines. The aim of this study is to evaluate the feasibility a mobile health intervention with text messages and behavior change theory in patients with cardiovascular disease for a duration of 3 months after completion of a cardiac rehabilitation program. An intervention consisting of action planning, text messages, and coordinator support is tested in a feasibility trial design with 40 expected participants.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | April 30, 2022 |
Est. primary completion date | April 30, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age =18 years. - Participant in an exercise-based cardiac rehabilitation program in either hospital or municipality setting. - Access to a personal mobile phone and Danish telephone number. - Able to walk 3 meters without assistance. Exclusion Criteria: - Insufficient Danish language proficiency to read and understand text messages and questionnaires. - Patients cognitively or mentally unable to participate. - Terminal patients and patients with a life expectancy of less than 3 months. |
Country | Name | City | State |
---|---|---|---|
Denmark | Holbæk Hospital | Holbæk | |
Denmark | City of Slagelse (municipality) | Korsør | |
Denmark | Slagelse Hospital | Slagelse |
Lead Sponsor | Collaborator |
---|---|
Slagelse Hospital | City of Slagelse (municipality), Holbaek Sygehus, University College Copenhagen, University of Southern Denmark |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Health-related quality of life, general | EQ-5D-5L evaluates health status in 5 dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension is rated from 1 (best) to 5 (worst) and overall health is rated on a 0 to 100 VAS scale. | Change from baseline to 12 weeks | |
Other | Health-related quality of life, VAS subscale | EQ-5D-5L evaluates health status in 5 dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension is rated from 1 (best) to 5 (worst) and overall health is rated on a 0 to 100 VAS scale. | Change from baseline to 12 weeks | |
Other | Health-related quality of life, heart-specific | HeartQoL is used to measure heart-specific quality of life in the past 4 weeks. Range from 0 (worst) to 42 (best) . | Change from baseline to 12 weeks | |
Other | Anxiety and depression | Hospital Anxiety and Depression Scale (HADS). HADS gives a score for each of anxiety and depression, each ranging from 0 (best) to 21 (worst). | Change from baseline to 12 weeks | |
Other | Physical function, self-reported | WHO Disability Assessment Schedule 2.0 (WHODAS 2.0),12-item version. WHODAS is a generic assessment instrument for health and disability. Range from 12 (no disability) to 60 (highest disability or loss of function). | Change from baseline to 12 weeks | |
Other | Comorbidity | Disease Burden: Morbidity Assessment by Self-Report used to evaluated a list of common chronic conditions affect the participants' daily activities. Each condition (that the participant has) is rated from 1 (not at all) to 5 (a lot) in regard to how much it limits daily activities. | Change from baseline to 12 weeks | |
Other | Self-efficacy, managing chronic disease | Self-efficacy of managing chronic disease 6 items scale. Score is calculated as the mean of 6 items, each scored from 1 (low self-efficacy) to 10 (high self-efficacy). | Change from baseline to 12 weeks | |
Other | Motivational Self-efficacy | Motivational self-efficacy, HAPA items by Schwartzer R., 2 items each rated on a scale from 1 (low self-efficacy) to 4 (high self-efficacy). | Change from baseline to 12 weeks | |
Other | Coping Self-efficacy | Coping self-efficacy, HAPA items by Schwartzer R., 2 items each rated on a scale from 1 (low self-efficacy) to 4 (high self-efficacy). | Change from baseline to 12 weeks | |
Other | Recovery Self-efficacy | Recovery self-efficacy, HAPA items by Schwartzer R., 2 items each rated on a scale from 1 (low self-efficacy) to 4 (high self-efficacy). | Change from baseline to 12 weeks | |
Primary | Recruitment | Green: Mean of =0.75 recruited participants per week per site
Amber: Mean of 0.5-0.74 recruited participants per week per site Red: Mean of <0.5 recruited participants per week per site |
Baseline | |
Primary | Attrition/retention through follow-up assessment session | Green: =80% retention of participants through follow up
Amber: 50-79% retention of participants through follow up Red: <50% retention of participants through follow up |
Up to 12 weeks | |
Primary | Accelerometer data completeness | Green: Accelerometer data from both baseline and follow-up available on =80% of completing participants
Amber: Data available on 50-79% of completing participants Red: Data available on <50% of completing participants |
Baseline | |
Primary | Accelerometer data completeness | Green: Accelerometer data from both baseline and follow-up available on =80% of completing participants
Amber: Data available on 50-79% of completing participants Red: Data available on <50% of completing participants |
12 weeks | |
Primary | Response rate on patient reported outcomes | Green: =90% of participants attending baseline and follow-up assessment return patient reported outcomes
Amber: 75-89% of patients attending baseline and follow-up assessment return patient reported outcomes Red: <75% of participants attending baseline and follow-up assessment return patient reported outcomes |
Baseline | |
Primary | Response rate on patient reported outcomes | Green: =90% of participants attending baseline and follow-up assessment return patient reported outcomes
Amber: 75-89% of patients attending baseline and follow-up assessment return patient reported outcomes Red: <75% of participants attending baseline and follow-up assessment return patient reported outcomes |
12 weeks | |
Primary | Coordinator time spent, minutes per participant throughout the intervention | Green: Mean coordinator time spent of =30 minutes per participant
Amber: Mean coordinator time spent of 31-60 minutes per participant Red: Mean coordinator time spent of >60 minutes per participant |
12 weeks | |
Primary | Response rate (adherence) to weekly follow-up messages | Green: =75% of patients respond to at least 75% of messages
Amber: 50-74% of patients respond to at least 75% of messages Red: <50% of patients respond to at least 75% of messages |
12 weeks | |
Primary | Acceptability of text message component, single item | Green: =75% of participants find text messages acceptable
Amber: 50-74% of participants find text messages acceptable Red: <50% of participants find text messages acceptable |
12 weeks | |
Secondary | Physical activity, objectively measured | Measured with thigh and wrist accelerometers | Change from baseline to 12 weeks | |
Secondary | Physical function, walking | 6 minute walking test | Change from baseline to 12 weeks | |
Secondary | Physical function, sit-to-stand | 30-second sit-to-stand test | Change from baseline to 12 weeks | |
Secondary | Physical activity, subjectively measured | The International Physical Activity Questionnaire (IPAQ) is used to measure physical activity in the past 7 days. 0 is minimum (completely inactivty). | Change from baseline to 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Active, not recruiting |
NCT05896904 -
Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction
|
N/A | |
Completed |
NCT05077293 -
Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
|
||
Recruiting |
NCT05631275 -
The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
|
||
Enrolling by invitation |
NCT05564572 -
Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology
|
N/A | |
Enrolling by invitation |
NCT05009706 -
Self-care in Older Frail Persons With Heart Failure Intervention
|
N/A | |
Recruiting |
NCT04177199 -
What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
|
||
Terminated |
NCT03615469 -
Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY)
|
N/A | |
Recruiting |
NCT06340048 -
Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure
|
Phase 1/Phase 2 | |
Recruiting |
NCT05679713 -
Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
|
||
Completed |
NCT04254328 -
The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure
|
N/A | |
Completed |
NCT03549169 -
Decision Making for the Management the Symptoms in Adults of Heart Failure
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05538611 -
Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
|
||
Recruiting |
NCT04262830 -
Cancer Therapy Effects on the Heart
|
||
Completed |
NCT06026683 -
Conduction System Stimulation to Avoid Left Ventricle Dysfunction
|
N/A | |
Withdrawn |
NCT03091998 -
Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support
|
Phase 1 | |
Recruiting |
NCT05564689 -
Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
|